Induced pluripotent stem cell (iPSC)-derived organoids provide models to study human organ development. Single-cell transcriptomics enable highly resolved descriptions of cell states within these systems; however, approaches are needed to directly measure lineage relationships. Here we establish iTracer, a lineage recorder that combines reporter barcodes with inducible CRISPR–Cas9 scarring and is compatible with single-cell and spatial transcriptomics. We apply iTracer to explore clonality and lineage dynamics during cerebral organoid development and identify a time window of fate restriction as well as variation in neurogenic dynamics between progenitor neuron families. We also establish long-term four-dimensional light-sheet microscopy for spatial lineage recording in cerebral organoids and confirm regional clonality in the developing neuroepithelium. We incorporate gene perturbation (iTracer-perturb) and assess the effect of mosaic TSC2 mutations on cerebral organoid development. Our data shed light on how lineages and fates are established during cerebral organoid formation. More broadly, our techniques can be adapted in any iPSC-derived culture system to dissect lineage alterations during normal or perturbed development.
25 September 2024 in Nature Biomedical Engineering
Bispecific antibodies (biAbs) used in cancer immunotherapies rely on functional autologous T cells, which are often damaged and depleted in patients with haematological malignancies and in other immunocompromised patients. The adoptive transfer of allogeneic T cells from healthy donors can enhance the efficacy of biAbs, but donor T cells binding to host-cell antigens cause an unwanted alloreactive response. Here we show that allogeneic T cells engineered with a T-cell receptor that does not convert antigen binding into cluster of differentiation 3 (CD3) signalling decouples antigen-mediated T-cell activation from T-cell cytotoxicity while preserving the surface expression of the T-cell-receptor–CD3 signalling complex as well as biAb-mediated CD3 signalling and T-cell activation. In mice with CD19+ tumour xenografts, treatment with the engineered human cells in combination with blinatumomab (a clinically approved biAb) led to the recognition and clearance of tumour cells in the absence of detectable alloreactivity. Our findings support the development of immunotherapies combining biAbs and ‘off-the-shelf’ allogeneic T cells.
A major challenge in biology is predicting how cells transition between states over time and how perturbations disrupt these transitions. Understanding such dynamics is critical for identifying interventions that reverse pathological programs or reprogram cells toward desired states. Although recent computational approaches can predict single-cell perturbation responses in silico , they cannot predict responses across dynamic cell trajectories, for example how early perturbations reconfigure later cell states. To address this gap, we introduce PerturbGen, a generative foundation model trained on over 100 million single-cell transcriptomes that predicts perturbation responses along cellular trajectories. PerturbGen predicts how genetic perturbation at source state shapes downstream states, alters gene programs and trajectories across time, for example in differentiation or disease progression. We apply PerturbGen to three newly generated multi-condition human single-cell datasets spanning immune responses, hematopoiesis and skin development. In an in vivo immune challenge, PerturbGen predicts that knocking out an IL1B signal in myeloid cells attenuates later cytokine-interferon programs, with downstream changes consistent with a reversal of IL-1β stimulation signature. In hematopoiesis, anchoring perturbation-induced programs to human genetics enables simulation of monogenic blood disorders, recapitulates established disease-associated biology whilst systematically revealing lineage-specific programs, including in lineages where this was not previously possible. In skin organoids, PerturbGen predicted that Wnt activation enhances stromal differentiation recapitulating the trajectory observed in human prenatal skin, findings that were functionally validated by experimentally activating Wnt signaling. Together, PerturbGen extends modeling of gene perturbations from static to dynamic cellular systems. We envision PerturbGen enabling the creation of in silico , trajectory-aware perturbation atlases and virtual cells across diverse biological scenarios, supporting optimization of disease models and prioritization of candidate molecular interventions for therapeutic discovery.
30 October 2024 in International Journal of Pharmaceutics
A major challenge in human genetics is to connect disease-associated variants to the cellular functions they perturb. Variants associated with immune-mediated disease have implicated CD4⁺ T-cell activation as a disease-causal process; however, it remains unresolved whether these variants act on pathways initiating cell division, driving effector differentiation, or maintaining proliferative capacity. Activated T cells comprise mixtures of cells that have undergone different numbers of divisions, potentially obscuring genetic effects that act at specific stages of this process. Here, we study CD4⁺ T-cell activation through cell division using division-resolved single-cell transcriptomics of naive, memory and regulatory T cells. We show that division state constitutes an important axis of transcriptional organisation, with approximately one third of genes exhibiting division-dependent regulation across shared and subset-specific programmes. We develop CellDivider , a machine-learning model that accurately infers proliferative state directly from single-cell transcriptomes, enabling a scalable approach for cohort level mapping of variant effects on cell proliferation phenotypes. Incorporating inferred division state into single-cell eQTL models reveals regulatory effects that are attenuated or missed when cells are analysed by activation time alone. Finally, we resolve gene expression programmes that govern distinct stages of T cell activation and proliferation. We show that polygenic immune disease risk preferentially converges on early activation and differentiation modules, rather than on proliferative capacity itself. Consistent with this model, division-resolved analysis of the pleiotropic immune risk gene RPS26 localises its genetic effects to early division states, providing mechanistic insight into its broad disease associations. Together, these findings illustrate how resolving dynamic cellular consequences of activation sharpens variant-to-function inference in immune disease genetics.